rs104895512
Variant summary
Our verdict is Likely pathogenic. Variant got 9 ACMG points: 10P and 1B. PM2PP5_Very_StrongBP4
The NM_001405531.1(NLRP7):c.2248C>G(p.Leu750Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000102 in 1,614,026 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_001405531.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NLRP7 | NM_001127255.2 | c.2248C>G | p.Leu750Val | missense_variant | 6/11 | ENST00000592784.6 | NP_001120727.1 | |
NLRP7 | NM_001405531.1 | c.2248C>G | p.Leu750Val | missense_variant | 8/13 | NP_001392460.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NLRP7 | ENST00000592784.6 | c.2248C>G | p.Leu750Val | missense_variant | 6/11 | 1 | NM_001127255.2 | ENSP00000468706 | P2 |
Frequencies
GnomAD3 genomes AF: 0.0000986 AC: 15AN: 152158Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000529 AC: 133AN: 251412Hom.: 0 AF XY: 0.000353 AC XY: 48AN XY: 135886
GnomAD4 exome AF: 0.000102 AC: 149AN: 1461750Hom.: 0 Cov.: 34 AF XY: 0.0000811 AC XY: 59AN XY: 727180
GnomAD4 genome AF: 0.0000985 AC: 15AN: 152276Hom.: 0 Cov.: 32 AF XY: 0.0000671 AC XY: 5AN XY: 74472
ClinVar
Submissions by phenotype
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 13, 2019 | For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site, but this prediction has not been confirmed by published transcriptional studies. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. This variant has been observed in multiple individuals affected with autosomal recessive familial recurrent hydatidiform mole 1 (PMID: 18039680, 26956250, 19066229, 23354651) and it is found at high frequency in control individuals of Mexican descent (PMID: 23354651). ClinVar contains an entry for this variant (Variation ID: 97750). This variant is present in population databases (rs104895512, ExAC 0.5%), and has an allele count higher than expected for a pathogenic variant (PMID: 28166811). This sequence change replaces leucine with valine at codon 750 of the NLRP7 protein (p.Leu750Val). The leucine residue is moderately conserved and there is a small physicochemical difference between leucine and valine. - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Sep 01, 2022 | In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 23354651, 26956250, 24105752, 18039680, 19066229, 21659348, 33583041, 34189227, 33751332) - |
Hydatidiform mole, recurrent, 1 Pathogenic:1Other:1
not provided, no classification provided | literature only | Unité médicale des maladies autoinflammatoires, CHRU Montpellier | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Aug 29, 2018 | The NLRP7 c.2248C>G (p.Leu750Val) variant has been reported three studies and is found in a total of 21 probands with recurrent hydatidiform mole including 15 in a homozygous state, six in a compound heterozygous state, and at least five in a heterozygous state (Kou et al. 2008; Deveault et al. 2009; Estrada et al. 2013). One of the homozygous probands had unaffected parents and sister that were heterozygous for the p.Leu750Val variant (Deveault et al. 2009). The p.Leu750Val variant was reported in five of 460 control chromosomes and is reported at a frequency of 0.005023 in the Latino population of the Exome Aggregation Consortium. Based on the collective evidence, the p.Leu750Val is classified as pathogenic for hydatidiform mole. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at